Robert DelAversano - 14 Apr 2025 Form 4 Insider Report for Grace Therapeutics, Inc. (GRCE)

Role
Principal Financial Officer
Signature
/s/ Robert DelAversano
Issuer symbol
GRCE
Transactions as of
14 Apr 2025
Transactions value $
$0
Form type
4
Filing time
16 Apr 2025, 20:58:50 UTC
Previous filing
08 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRCE Stock Option (Right to Buy) Award $0 +20,130 $0.000000 20,130 14 Apr 2025 Common Stock 20,130 $2.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests quarterly in substantially equal installments over a 3-year period, subject to the Reporting Person's continuous service as of each vesting date.

Remarks:

Exhibit 24: Power of Attorney